Relationship Between Fasting Glucose, HbA1c Levels, and the SYNTAX Score 2 in Patients With Non-ST-Elevation
Alparslan Kilic1, Onur Baydar1
1Department of Cardiology, 52979Koc University Hospital, Istanbul, Turkey.
Insights
In non-diabetic patients with non-ST-elevation myocardial infarction (NSTEMI), admission glycosylated hemoglobin (HbA1c) levels showed a stronger correlation with coronary artery disease (CAD) severity than fasting glucose. This finding highlights HbA1c as a potential marker for CAD complexity in this population.
Area of Science:
- Cardiology
- Endocrinology
- Medical Diagnostics
Background:
- Coronary artery disease (CAD) severity assessment is crucial for guiding treatment in patients with non-ST-elevation myocardial infarction (NSTEMI).
- The role of glycemic markers, specifically glycosylated hemoglobin (HbA1c) and fasting glucose, in predicting CAD severity in non-diabetic NSTEMI patients requires further elucidation.
- The anatomical SYNTAX score 2 (SSII) is a validated tool for evaluating CAD complexity.
Purpose of the Study:
- To investigate the correlation between admission glycosylated hemoglobin (HbA1c) and fasting glucose levels with coronary artery disease (CAD) severity in non-diabetic patients experiencing non-ST-elevation myocardial infarction (NSTEMI).
- To determine which glycemic marker, HbA1c or fasting glucose, better predicts CAD severity as assessed by the SSII.
Main Methods:
- A retrospective analysis was conducted on 359 non-diabetic patients hospitalized with NSTEMI who underwent coronary angiography.
- Coronary artery disease severity was quantified using the SYNTAX Score 2 (SSII).
- Patients were stratified into tertiles based on SSII scores (low, mid, high), and correlations with admission HbA1c and fasting glucose levels were analyzed.
Main Results:
- A significantly stronger correlation was observed between HbA1c levels and SSII (r = 0.901, P < .001) compared to fasting glucose and SSII (r = 0.378, P < .001).
- Higher HbA1c levels and a history of hypertension were identified as independent risk factors for high SSII scores (OR: 2.2 and 1.1, respectively).
- The average patient age was 57.1 ± 10.9 years, with 52.1% males.
Conclusions:
- Admission HbA1c levels are a more robust indicator of coronary artery disease severity in non-diabetic NSTEMI patients than fasting glucose levels.
- HbA1c may serve as a valuable predictive marker for complex CAD in this specific patient cohort.
- These findings underscore the importance of evaluating glycemic control, even in non-diabetic individuals, for comprehensive risk stratification in NSTEMI.
Abstract:
We evaluated if admission glycosylated hemoglobin (HbA1c) and fasting glucose levels are correlated with the severity of coronary artery disease (CAD) in non-ST-elevation myocardial infarction (NSTEMI), nondiabetic, patients. Coronary artery disease severity, according to the anatomical synergy between percutaneous coronary intervention (PCI) with taxus and cardiac surgery (SYNTAX) score 2 (SSII), was retrospectively evaluated in 359 nondiabetic patients hospitalized with NSTEMI who underwent coronary angiography. Glucose intolerance was assessed by serum fasting glucose and HbA1c levels. We stratified patients according to tertiles of SSII (≤21.5, 21.5-30.6, and ≥30.6). These score ranges were defined as SSII low, SSII mid, and SSII high, respectively. The average age of the patients was 57.1 ± 10.9 years; 189 (52.1%) patients were males. The average fasting glucose was 114 ± 52 mg/dL, HbA1c was 5.8% ± 0.9%, and SSII was 18.9 ± 10.3. A stronger correlation was found between HbA1c and SSII than fasting glucose and SSII (r1 = 0.901, P < .001, r2 = 0.378, P < .001, respectively), and HbA1c level and hypertension were independent risk factors for SSII high (odds ratio [OR]: 2.2 (95% CI: 0.5-9.0, P < .001; OR: 1.1 (1.0-1.3), P = .007, respectively). In conclusion, in nondiabetic patients with NSTEMI, HbA1c levels correlated with CAD severity as measured by the SSII.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Metabolic States of the Body: Fasting and Starvation
Acute Coronary Syndrome III: Diagnostic Studies
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...


